4.7 Article

Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment

Related references

Note: Only part of the references are listed.
Review Oncology

Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery-A systematic review and meta-analysis

Domhnall J. O'Connor et al.

Summary: Patients with invasive lobular carcinoma of the breast are less likely to achieve complete pathological response, receive breast-conserving surgery, and have negative margin status compared to patients with invasive ductal carcinoma.

BREAST (2022)

Article Surgery

Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater

Mary Kathryn Abel et al.

Summary: For patients with ILC tumors measuring >= 4 cm, there was no significant difference in recurrence free survival between those treated with breast conservation therapy (BCT) and mastectomy, as long as negative margins are achieved. The key factor affecting outcomes is the margin status.

AMERICAN JOURNAL OF SURGERY (2021)

Article Oncology

Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB)

Rita A. Mukhtar et al.

Summary: Primary surgery remains the most common treatment strategy for patients with ILC. However, there was a slight decrease in NAC use while a small increase in long-course NET was observed. Long-course NET was associated with increased rates of BCS and less extensive axillary surgery in specific patient populations.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Medicine, General & Internal

Concordance Between Clinical and Pathological Response Assessment After Neo-Adjuvant Chemotherapy in Patients With Invasive Lobular Carcinoma

Aisha Shaikh et al.

Summary: This study aimed to determine the concordance between clinical and pathological response assessments after NAC in ILC cases. The majority of cases showed partial pathological response, with only a few cases achieving complete pathological response. The study found low concordance rates between clinical and pathological assessments using different assessment systems.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Imaging of Breast Cancers With Predilection for Nonmass Pattern of Growth: Invasive Lobular Carcinoma and DCIS-Does Imaging Capture It All?

Olena Weaver et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2020)

Article Surgery

Characterizing Response to Neoadjuvant Chemotherapy in Invasive Lobular Breast Carcinoma

Luis A. Riba et al.

JOURNAL OF SURGICAL RESEARCH (2019)

Article Obstetrics & Gynecology

Association of Menopausal Status, Expression of Progesterone Receptor and Ki67 to the Clinical Response to Neoadjuvant Chemotherapy in Luminal Breast Cancer

Leonardo Roberto da Silva et al.

REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA (2019)

Article Surgery

Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?

Karen Tsung et al.

AMERICAN JOURNAL OF SURGERY (2018)

Article Oncology

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer

Esther H. Lips et al.

BREAST CANCER RESEARCH AND TREATMENT (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Invasive Lobular Carcinoma of the Breast: Spectrum of Mammographic, US, and MR Imaging Findings

January K. Lopez et al.

RADIOGRAPHICS (2009)

Article Oncology

Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis

D Mauri et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)

Article Medicine, General & Internal

Trends in incidence rates of invasive lobular and ductal breast carcinoma

CI Li et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)